Dov A. Goldstein Net Worth & Insider Trades

Dov A. Goldstein - Director, Neubase Therapeutics, Inc

As of September 12, 2022

What is Dov A. Goldstein's Net Worth?

The current estimated net worth of Neubase Therapeutics, Inc's Director, Dov A. Goldstein, is estimated to be about $63.72M . Dov A. Goldstein owns about 30,000 units of Neubase Therapeutics, Inc common stock. In the last 3 years at Neubase Therapeutics, Inc, Dov A. Goldstein has sold an estimated value of $0 worth.

What is Dov A. Goldstein's Past Insider Trading?

Dov A. Goldstein's largest purchase order was 12,000 units , worth over $60K on April 27, 2021. In total, Dov A. Goldstein has made about 7 transactions over 3 years of their time at Neubase Therapeutics, Inc. Dov A. Goldstein usually trades in September, with the busiest year in 2021. The most recent transaction was a purchase order of 8,000 units , worth over $38K on June 21, 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What are Neubase Therapeutics, Inc's Past Insider Trades?

Neubase Therapeutics, Inc's most recent insider trade came on April 1, 2022 by William Mann who bought 6,200 units worth $11.9K . In the last 2 years, insiders at Neubase Therapeutics, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in September, with the busiest year in 2022. The most active traders at the company are Dietrich A Stephan, President and CEO,  Dov A. Goldstein, Director,  and Eric I Richman, Director .

NeuBase Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1